Ocugen (OCGN) Operating Expenses (2014 - 2026)
Ocugen (OCGN) posted Operating Expenses of $19.4 million for Q1 2026, up 15.3% on a QoQ basis from $16.8 million in Q4 2025, and up 21.21% year-over-year from $16.0 million in Q1 2025.
Ocugen (OCGN) Operating Expenses (2014 - 2026) Analysis & Trends
Ocugen's Operating Expenses history runs 13 years deep, the most recent figure standing at $19.4 million for Q1 2026.
- Quarterly Operating Expenses rose 21.21% year-over-year to $19.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.7 million (up 14.87% YoY) and the FY2025 annual result came in at $67.3 million, up 14.48% from the prior year.
- Operating Expenses was $19.4 million for Q1 2026 at Ocugen, up from $16.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $25.6 million in Q3 2022 and bottomed at $12.9 million in Q4 2023.
- A 5-year average of $18.2 million and a median of $16.8 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 176.75% — and 2023, when it sank 46.63%.
- Ocugen's Operating Expenses stood at $24.2 million in 2022, then sank by 46.63% to $12.9 million in 2023, then increased by 12.91% to $14.6 million in 2024, then grew by 15.05% to $16.8 million in 2025, then grew by 15.3% to $19.4 million in 2026.
- Business Quant data shows OCGN's Operating Expenses at $19.4 million in Q1 2026, $16.8 million in Q4 2025, and $19.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 19.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.37 Mn |
| Dec 31, 2025 | 16.80 Mn |
| Sep 30, 2025 | 19.38 Mn |
| Jun 30, 2025 | 15.17 Mn |
| Mar 31, 2025 | 15.98 Mn |
| Dec 31, 2024 | 14.60 Mn |
| Sep 30, 2024 | 14.39 Mn |
| Jun 30, 2024 | 16.59 Mn |
| Mar 31, 2024 | 13.23 Mn |
| Dec 31, 2023 | 12.93 Mn |
| Sep 30, 2023 | 16.13 Mn |
| Jun 30, 2023 | 24.03 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 24.23 Mn |
| Sep 30, 2022 | 25.58 Mn |
| Jun 30, 2022 | 22.22 Mn |
| Mar 31, 2022 | 19.53 Mn |
| Dec 31, 2021 | 14.57 Mn |
| Sep 30, 2021 | 10.79 Mn |
| Jun 30, 2021 | 25.61 Mn |